NRx Pharmaceuticals, Inc. NRXP
Set alert
2.17 USD -0.10 -4.41%
At close · Nov 2
2.20 +0.03 +1.38%
After hours · Nov 2, 7:57 PM ET
2.14 Day range 2.44
1.62 52-week range 5.06
- YTD
- -19.93%
- 1 year
- -30.00%
- Open
- 2.32
- Prev close
- 2.27
- Mkt cap
- 93.95M
- Vol
- 2.51M
- Avg vol
- 1.09M
- EPS
- -0.58
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.14
- High
- 2.44
- Forward P/E
- -1.12
- Beta
- 1.27
- Short ratio
- 4.80
- Inst. own
- 6.05%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 1.28
- 200-d avg
- 2.53
- 1y target
- 31.67
5D chart
Signals (77)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 3:30 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 10 hours ago |
| SMA: Bearish | Nov 2, 3:05 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:50 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 11 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 11 hours ago |
| SMA: Bullish | Nov 2, 2:15 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 2:15 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 1:10 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 11:55 AM | 14 hours ago |
| MACD: Buy Signal | Nov 2, 11:55 AM | 14 hours ago |
| SMA: Bearish | Nov 2, 10:35 AM | 15 hours ago |
| SMA: Bullish | Nov 2, 10:30 AM | 15 hours ago |
| SMA: Bearish | Nov 2, 10:10 AM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 10:10 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 10:05 AM | 16 hours ago |
| RSI: Overbought | Nov 2, 9:40 AM | 16 hours ago |
| SMA: Bullish | Nov 2, 9:30 AM | 16 hours ago |
| MACD: Buy Signal | Nov 2, 9:30 AM | 16 hours ago |
Newest 20 of 77.
Analyst view
Consensus: none
Price target (mean) 31.67 +1359.3% upside
Now 2.17
- Target (low)
- 19.00
- Target (mean)
- 31.67
- Target (high)
- 45.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.295 | -0.39 – -0.20 | -0.50 | +41.0% | 0 | 0.0% | 2 |
| Next quarter | -0.40 | -0.40 – -0.40 | -0.74 | +46.0% | 5.00M | 0.0% | 1 |
| Current year | -1.86 | -1.96 – -1.75 | -4.00 | +53.6% | 0 | 0.0% | 2 |
| Next year | -0.03 | -0.08 – 0.02 | -1.86 | +98.4% | 68.47M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Oct 30, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 21, 2024 | EF Hutton | Initiated | — | Buy |
| Sep 12, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Aug 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 7, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| May 25, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 9, 2022 | Ascendiant Capital | Initiated | — | Buy |
| Jun 30, 2022 | HC Wainwright & Co. | Initiated | — | Buy |